Cite
Mancuso A, Vedovati MC, Pierpaoli L, et al. PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort. Thromb Res. 2016;140:S191doi: 10.1016/S0049-3848(16)30173-6.
Mancuso, A., Vedovati, M. C., Pierpaoli, L., Paliani, U., Conti, S., Filippucci, E., Ascani, A., Radicchia, S., Galeotti, G., Agnelli, G., & Becattini, C. (2016). PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort. Thrombosis research, 140S191. https://doi.org/10.1016/S0049-3848(16)30173-6
Mancuso, A, et al. "PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort." Thrombosis research vol. 140 (2016): S191. doi: https://doi.org/10.1016/S0049-3848(16)30173-6
Mancuso A, Vedovati MC, Pierpaoli L, Paliani U, Conti S, Filippucci E, Ascani A, Radicchia S, Galeotti G, Agnelli G, Becattini C. PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort. Thromb Res. 2016 Apr;140:S191. doi: 10.1016/S0049-3848(16)30173-6. Epub 2016 Apr 08. PMID: 27161728.
Copy
Download .nbib